摘要Liver transplantation (LT) was offered to some colorectal cancer (CRC) patients with liver only metastases in the 1990s, however the treatment option was discontinued due to poor overall survival (OS) of 43% at 2 years posttransplant combined with the scarcity of donor organs at that time (1).
作者单位Department of Oncology, Oslo University Hospital, Oslo, Norway[1]Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway and Institute of Clinical Medicine, University of Oslo, Norway[2]